ARCHIVES

Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Without Advance Directives, Families Prolong Treatment

April 27, 2001

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005

Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center.

September 24, 2004

NIH Panel Urges Wider Treatment of Hepatitis C

June 14, 2002

Letter: The Lesson From Dana-Farber

July 28, 1995